Mintz advised the underwriters in connection with a $200 million public offering by Soleno Therapeutics, Inc. of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. The gross proceeds to Soleno from the offering were approximately $200 million before deducting underwriting discounts and commissions and other offering expenses. In addition, Soleno granted the underwriters a 30-day option to purchase up to an additional 352,941 shares of its common stock at the public offering price.

Goldman Sachs & Co. LLC, Guggenheim Securities, TD Cowen, Cantor and Oppenheimer & Co. acted as joint book-running managers for the offering.

The Mintz corporate team included Members William Hicks, John Rudy, Nishant Dharia and Jeffrey Cohan and Associates Samantha Silver, Gretchen Goyette, and Nicole Gaston. Member Joanne Hawana provided regulatory advice, Member Ari Feder provided tax advice, and Associate Edmund Koundakjian, PhD provided intellectual property advice. Members of the Mintz team are based in the Boston, New York and San Diego offices.